Table 1.
Clinical and biochemical characteristics of the patients.
| Parameter | Value (n = 69) |
|---|---|
| Age (years) | 51.7 ± 8.7 |
| Body mass index (kg/m2) | 28.7 ± 8.7 |
| Systolic blood pressure (mmHg) | 128 ± 15 |
| Diastolic blood pressure (mmHg) | 77 ± 9 |
| Total cholesterol (mmol/L) | 4.24 ± 0.83 |
| HDL cholesterol (mmol/L) | 1.20 ± 0.28 |
| LDL cholesterol (mmol/L) | 2.35 ± 0.70 |
| Triglycerides (mmol/L) | 1.65 ± 0.79 |
| Lipoprotein(a) (mg/L) | 1431 (11207–1783) |
| Apolipoprotein B (g/L) | 0.81 ± 0.22 |
| Apolipoprotein A1 (g/L) | 1.34 ± 0.19 |
| KIV-2 repeats (n) | 10.2 (5.8–13.5) |
| hs-CRP (mg/L) | 0.87 (0.37–1.93) |
| TNF-α (ng/L) | 3.91 (3.36–5.36) |
| IL-6 (ng/L) | 1.69 (1.20–2.53) |
| IL-8 (ng/L) | 13.50 (10.65–18.35) |
| D-dimer (µg/L) | 270 (190–482) |
| F VIII (IU/mL) | 1.56 (1.24–1.74) |
| TAFI (%) | 100.50 (86.00–110.25) |
| PAI-1 (ng/mL) | 36.50 (22.25–56.75) |
| OCP (Abs-sum) | 23.45 (19.78–28.13) |
| OHP (Abs-sum) | 6.60 (4.73–8.65) |
| OFP (%) | 71.54 ± 8.32 |
Data are median (lower–upper quartiles) or mean values ± standard deviation. HDL, high-density lipoprotein; LDL, low-density lipoprotein; KIV-2, kringle IV type 2; hs-CRP, high-sensitivity C-reactive protein; TNF-α, tumor necrosis factor-α; IL, interleukin; F VIII, factor VIII; TAFI, thrombin-activatable fibrinolysis inhibitor; PAI-1, plasminogen activator inhibitor-1; OCP, overall coagulation potential; OHP, overall hemostatic potential; OFP, overall fibrinolytic potential.